0001209191-18-032950.txt : 20180524
0001209191-18-032950.hdr.sgml : 20180524
20180524153216
ACCESSION NUMBER: 0001209191-18-032950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180522
FILED AS OF DATE: 20180524
DATE AS OF CHANGE: 20180524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Invesco Ltd.
CENTRAL INDEX KEY: 0000914208
STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282]
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36754
FILM NUMBER: 18857718
BUSINESS ADDRESS:
STREET 1: 1555 PEACHTREE STREET NE
STREET 2: SUITE 1800
CITY: ATLANTA
STATE: GA
ZIP: 30309
BUSINESS PHONE: 404-892-0896
MAIL ADDRESS:
STREET 1: 1555 PEACHTREE STREET NE
STREET 2: SUITE 1800
CITY: ATLANTA
STATE: GA
ZIP: 30309
FORMER NAME:
FORMER CONFORMED NAME: Invesco Ltd
DATE OF NAME CHANGE: 20080508
FORMER NAME:
FORMER CONFORMED NAME: Invesco PLC
DATE OF NAME CHANGE: 20080429
FORMER NAME:
FORMER CONFORMED NAME: Invesco Ltd.
DATE OF NAME CHANGE: 20071205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evofem Biosciences, Inc.
CENTRAL INDEX KEY: 0001618835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208527075
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 550-1900
MAIL ADDRESS:
STREET 1: 12400 HIGH BLUFF DRIVE
STREET 2: SUITE 600
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Neothetics, Inc.
DATE OF NAME CHANGE: 20140905
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-22
0
0001618835
Evofem Biosciences, Inc.
EVFM
0000914208
Invesco Ltd.
1555 PEACHTREE STREET NE
SUITE 1800
ATLANTA
GA
30309
0
0
1
0
Common stock, Par value $0.0001 per share
2018-05-22
4
P
0
2127659
4.69
A
9165157
I
See Footnotes
Warrants
7.50
2018-05-22
4
P
0
2127659
0.01
A
2018-05-24
2018-05-24
Common stock
425531
2127659
I
See Footnotes (2), (3) and (4)
The common stock and warrants were purchased from the underwriters in a public offering pursuant to a registration statement on Form S-1 (333- 224958). The shares of common stock and warrants were purchased at the public offering price.
Invesco Ltd. is the beneficial owner of 9,165,157 shares of common stock and 2,127,659 warrants acquired by its affiliates, Invesco Perpetual High Income Funda and Invesco Perpetual Income Fund.
Invesco Asset Management Ltd. is a subsidiary of Invesco Ltd., and it advises Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund.
As described in the Neothetics, Inc. Registration Statement on Form S-4 (File No. 333-221592) voting and investment power over the common stock and warrants held by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund is exercised by the directors of Invesco Asset Management Ltd. Neothetics, Inc. changed its name to Evofem Biosciences, Inc. on January 17, 2017.
Nancy Tomassone
2018-05-24